Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Breast Neoplasms | 22 | 2019 | 3633 | 2.01 | Why? |
| Receptor, ErbB-2 | 7 | 2019 | 267 | 1.60 | Why? |
| Triple Negative Breast Neoplasms | 3 | 2019 | 92 | 1.08 | Why? |
| Antineoplastic Agents, Hormonal | 4 | 2019 | 203 | 0.90 | Why? |
| Dendritic Cells | 2 | 2020 | 1330 | 0.89 | Why? |
| Diphosphonates | 2 | 2020 | 121 | 0.89 | Why? |
| Mevalonic Acid | 1 | 2020 | 24 | 0.88 | Why? |
| Aromatase Inhibitors | 2 | 2019 | 45 | 0.87 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 10 | 2019 | 1573 | 0.83 | Why? |
| Neoadjuvant Therapy | 4 | 2019 | 554 | 0.83 | Why? |
| RNA, Neoplasm | 1 | 2019 | 34 | 0.81 | Why? |
| Receptors, Progesterone | 3 | 2018 | 76 | 0.78 | Why? |
| Receptors, Estrogen | 4 | 2018 | 171 | 0.75 | Why? |
| Bevacizumab | 2 | 2018 | 149 | 0.74 | Why? |
| Biomarkers, Tumor | 6 | 2019 | 1314 | 0.68 | Why? |
| Lectins, C-Type | 1 | 2020 | 405 | 0.67 | Why? |
| Cell Adhesion Molecules | 1 | 2020 | 472 | 0.66 | Why? |
| Endosomes | 1 | 2020 | 490 | 0.65 | Why? |
| Receptors, Cell Surface | 1 | 2020 | 586 | 0.61 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1014 | 0.53 | Why? |
| Chemotherapy, Adjuvant | 8 | 2018 | 606 | 0.48 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.45 | Why? |
| Postmenopause | 4 | 2019 | 160 | 0.41 | Why? |
| Hyperglycemia | 1 | 2020 | 1363 | 0.38 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.34 | Why? |
| Terminal Care | 1 | 2017 | 928 | 0.33 | Why? |
| Neoplasm Metastasis | 4 | 2019 | 682 | 0.33 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.31 | Why? |
| Carcinoma, Ductal, Breast | 2 | 2018 | 149 | 0.31 | Why? |
| Glycosylation | 2 | 2020 | 1255 | 0.30 | Why? |
| Glucose | 2 | 2020 | 573 | 0.30 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.28 | Why? |
| Protein Domains | 4 | 2020 | 6563 | 0.27 | Why? |
| Disease-Free Survival | 6 | 2018 | 1654 | 0.27 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.26 | Why? |
| Cyclophosphamide | 4 | 2018 | 387 | 0.26 | Why? |
| Survival Analysis | 6 | 2019 | 7592 | 0.26 | Why? |
| Recombination, Genetic | 2 | 2020 | 1265 | 0.26 | Why? |
| Doxorubicin | 4 | 2018 | 313 | 0.25 | Why? |
| Viral Nonstructural Proteins | 1 | 2021 | 4810 | 0.25 | Why? |
| Virulence | 2 | 2020 | 2172 | 0.25 | Why? |
| Neoplasm, Residual | 2 | 2019 | 147 | 0.23 | Why? |
| Bone Neoplasms | 2 | 2019 | 287 | 0.23 | Why? |
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2020 | 20 | 0.23 | Why? |
| Immunological Synapses | 1 | 2020 | 6 | 0.22 | Why? |
| Cognition Disorders | 2 | 2018 | 574 | 0.22 | Why? |
| Pan troglodytes | 1 | 2020 | 157 | 0.21 | Why? |
| Leprostatic Agents | 1 | 2020 | 94 | 0.21 | Why? |
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 43 | 0.21 | Why? |
| Paclitaxel | 2 | 2018 | 124 | 0.20 | Why? |
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 44 | 0.20 | Why? |
| Asia, Southeastern | 1 | 2021 | 390 | 0.20 | Why? |
| Sequence Homology | 1 | 2021 | 448 | 0.20 | Why? |
| Denosumab | 1 | 2019 | 49 | 0.20 | Why? |
| Human Embryonic Stem Cells | 1 | 2021 | 199 | 0.19 | Why? |
| Humans | 47 | 2021 | 930598 | 0.19 | Why? |
| Carbon | 1 | 2021 | 269 | 0.19 | Why? |
| HMGB1 Protein | 1 | 2020 | 223 | 0.18 | Why? |
| Epothilones | 1 | 2017 | 2 | 0.18 | Why? |
| Craniotomy | 1 | 2019 | 123 | 0.18 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 349 | 0.18 | Why? |
| Prediabetic State | 1 | 2020 | 200 | 0.17 | Why? |
| Antineoplastic Agents | 3 | 2018 | 3550 | 0.17 | Why? |
| Decision Making, Computer-Assisted | 1 | 2017 | 61 | 0.17 | Why? |
| Gene Expression Profiling | 2 | 2019 | 3788 | 0.17 | Why? |
| Cognition | 2 | 2018 | 1394 | 0.17 | Why? |
| Bone Density Conservation Agents | 1 | 2019 | 209 | 0.17 | Why? |
| Network Meta-Analysis | 1 | 2019 | 426 | 0.17 | Why? |
| Animals | 7 | 2021 | 78931 | 0.16 | Why? |
| Selection, Genetic | 1 | 2020 | 691 | 0.16 | Why? |
| Cholesterol | 1 | 2021 | 660 | 0.16 | Why? |
| Species Specificity | 1 | 2020 | 1356 | 0.16 | Why? |
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 98 | 0.16 | Why? |
| Drug Administration Schedule | 3 | 2018 | 2324 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
| Cattle | 1 | 2020 | 1336 | 0.15 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2020 | 572 | 0.15 | Why? |
| Remission Induction | 1 | 2019 | 950 | 0.15 | Why? |
| Peripheral Nervous System Diseases | 1 | 2018 | 193 | 0.15 | Why? |
| Neoplasm Recurrence, Local | 3 | 2018 | 1063 | 0.15 | Why? |
| Pennsylvania | 1 | 2017 | 558 | 0.15 | Why? |
| Organoids | 1 | 2021 | 840 | 0.14 | Why? |
| Coronavirus | 2 | 2021 | 18339 | 0.14 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.14 | Why? |
| Women | 1 | 2017 | 159 | 0.14 | Why? |
| Triazoles | 2 | 2017 | 440 | 0.14 | Why? |
| Cats | 1 | 2020 | 1890 | 0.13 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.13 | Why? |
| Nitriles | 2 | 2017 | 1053 | 0.13 | Why? |
| Pathology, Clinical | 1 | 2018 | 407 | 0.13 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.13 | Why? |
| Autophagy | 1 | 2020 | 960 | 0.13 | Why? |
| Dogs | 1 | 2020 | 2529 | 0.12 | Why? |
| Zinc | 1 | 2020 | 817 | 0.12 | Why? |
| Prognosis | 9 | 2019 | 32490 | 0.12 | Why? |
| Viral Tropism | 1 | 2020 | 1329 | 0.12 | Why? |
| Brain Neoplasms | 1 | 2019 | 669 | 0.12 | Why? |
| Viral Proteins | 2 | 2021 | 7370 | 0.12 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.11 | Why? |
| Host-Pathogen Interactions | 3 | 2020 | 11041 | 0.11 | Why? |
| Lymphatic Metastasis | 3 | 2018 | 537 | 0.11 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.11 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.10 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.10 | Why? |
| Betacoronavirus | 4 | 2021 | 204454 | 0.10 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.10 | Why? |
| Taxoids | 2 | 2018 | 45 | 0.09 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.09 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
| Phyllodes Tumor | 1 | 2006 | 5 | 0.09 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.08 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.08 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.08 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.08 | Why? |
| Protein Binding | 2 | 2020 | 11430 | 0.08 | Why? |
| Female | 21 | 2020 | 380317 | 0.08 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.08 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.08 | Why? |
| Chiroptera | 1 | 2021 | 3530 | 0.08 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.07 | Why? |
| Mastectomy | 3 | 2018 | 536 | 0.07 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Long-Term Care | 1 | 2017 | 2047 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.07 | Why? |
| Middle Aged | 18 | 2020 | 270681 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Osteoporosis | 1 | 2010 | 410 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Adult | 13 | 2020 | 244371 | 0.06 | Why? |
| African Americans | 1 | 2017 | 3363 | 0.06 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.05 | Why? |
| Mice | 1 | 2020 | 21357 | 0.05 | Why? |
| Prescription Fees | 1 | 2019 | 10 | 0.05 | Why? |
| Aged | 13 | 2020 | 215776 | 0.05 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.05 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.05 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.05 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2018 | 69 | 0.05 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.05 | Why? |
| Estrogen Receptor alpha | 1 | 2017 | 40 | 0.04 | Why? |
| Anthracyclines | 1 | 2017 | 65 | 0.04 | Why? |
| Bridged-Ring Compounds | 1 | 2017 | 45 | 0.04 | Why? |
| Markov Chains | 1 | 2019 | 502 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.04 | Why? |
| Pathologists | 1 | 2018 | 168 | 0.04 | Why? |
| Genetic Therapy | 1 | 2021 | 409 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
| Models, Economic | 1 | 2019 | 316 | 0.04 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.04 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2021 | 584 | 0.04 | Why? |
| Body Image | 1 | 2017 | 96 | 0.04 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.04 | Why? |
| United States | 2 | 2020 | 46150 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.04 | Why? |
| Smokers | 1 | 2021 | 550 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| Piperazines | 1 | 2018 | 445 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2016 | 9335 | 0.03 | Why? |
| Memory | 1 | 2015 | 137 | 0.03 | Why? |
| Autoimmunity | 1 | 2021 | 841 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.03 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2020 | 1316 | 0.03 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.03 | Why? |
| Health Expenditures | 1 | 2019 | 904 | 0.03 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2019 | 1142 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Bone Resorption | 1 | 2010 | 61 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Educational Status | 1 | 2015 | 1451 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.02 | Why? |
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 59 | 0.02 | Why? |
| Bone Density | 1 | 2010 | 335 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Endothelin-1 | 1 | 2006 | 69 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Mastectomy, Segmental | 1 | 2006 | 124 | 0.02 | Why? |
| Ki-67 Antigen | 1 | 2006 | 139 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Blood Glucose | 1 | 2020 | 3642 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Fatigue | 1 | 2017 | 2479 | 0.02 | Why? |
| Staining and Labeling | 1 | 2006 | 169 | 0.02 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 1692 | 0.02 | Why? |
| Epithelium | 1 | 2006 | 330 | 0.02 | Why? |
| Treatment Outcome | 3 | 2017 | 51732 | 0.02 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2006 | 310 | 0.02 | Why? |
| Aging | 1 | 2020 | 3581 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Primary Prevention | 1 | 2010 | 778 | 0.02 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.01 | Why? |
| Biomedical Research | 1 | 2021 | 5270 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2015 | 9893 | 0.01 | Why? |
| Triage | 1 | 2018 | 7151 | 0.01 | Why? |
| Prostatic Neoplasms | 1 | 2010 | 1637 | 0.01 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Case-Control Studies | 1 | 2015 | 17671 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Male | 3 | 2020 | 367725 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Disease Progression | 1 | 2006 | 13580 | 0.01 | Why? |